- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Take a Chill Pill
Pharmaceutical Executive
In the spirit of lawn chair cogitation and hammock-spun reverie, Pharm Exec invites you to submit your own verses-pharma-related, of course-to be published on our website in late August.
The "tawny streaks and shades" of summer sunlight, as Walt Whitman put it, have a mellowing effect; leisurely hours spent in scenic locales, on vacation or just out on the weekend, provide an opportunity for unhurried thought and easy reflection ("heat dome" notwithstanding). In the spirit of lawn chair cogitation and hammock-spun reverie, Pharm Exec invites you to submit your own verses—pharma-related, of course—to be published on our website in late August. Send those jottings from the post-conference tarmac, the hotel bar, or the family vacation to bcomer@advanstar.com, if you are so inclined. Our pseudonymous colleague Stix Daley has contributed one of his recent scribblings to kick things off. Summer will be gone soon, so take it slow while you can, and enjoy.
Pharmacopoeticsby Stix Daley
Longitudinal studies on red meat with clever endpoints.
Freedom to choose cigarettes and their adverse events.
By QALY, I develop the best immunity
I mean by golly.
Policy and people need most toexpire—
in their due time of course.
Meantime I’ve mislaid the data
that I
well I guess that I
ought to report.
Fee-for-service reimagined as
Hippocratical aphorism.
A cunning caduceus loosed
in the waiting room.
To Asclepius’s chagrin.
Even our immune systems are uniting
in mutiny
Coffee cup copays a fair market value
or just an encephalographic
image problem.
Commodities traders and doctors
know better.
Or regular Tories.
I mean no better.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start
October 30th 2024By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.
